Related Experiment Video
Updated: May 19, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Controversies in prediabetes: do we have a diagnosis?
Priscilla Hollander1, Craig Spellman
1Baylor Endocrine Center, Dallas, TX 75246, USA. priscilh@baylorhealth.edu
Postgraduate Medicine
|August 24, 2012
Summary
Prediabetes affects over a third of US adults, increasing risks for type 2 diabetes and heart disease. Early screening and consistent diagnostic criteria are crucial for effective prevention and management.
Area of Science:
- Endocrinology
- Public Health
- Preventive Medicine
Background:
- Over one-third of US adults have prediabetes, a condition often undiagnosed.
- Prediabetes significantly elevates the risk of developing type 2 diabetes mellitus (T2DM) and cardiovascular diseases.
- Early interventions, including lifestyle changes and pharmacotherapy, can prevent or delay T2DM onset.
Purpose of the Study:
- To review current organizational guidelines for prediabetes diagnosis.
- To analyze recent studies on the predictive value of different diagnostic criteria for T2DM progression.
- To discuss the implications of varying diagnostic criteria and treatment outcomes for preventive care.
Main Methods:
- Review of guidelines from multiple health organizations.
- Analysis of recent clinical trials and research studies on prediabetes and T2DM prevention.
- Synthesis of data on diagnostic criteria and intervention effectiveness.
Main Results:
- A lack of consensus exists among organizations regarding prediabetes diagnostic criteria.
- Different criteria identify varying patient subpopulations, complicating screening and diagnosis.
- Recent trials show promise for lifestyle modification and pharmacotherapy in delaying T2DM, but outcomes require further clarification.
Conclusions:
- Informed scientific debate is needed regarding standardized prediabetes diagnostic criteria.
- Clearer guidelines are essential for effective screening and preventive care strategies.
- Addressing diagnostic inconsistencies is vital for managing prediabetes and reducing T2DM incidence.
Related Concept Videos
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...